105 related articles for article (PubMed ID: 38954678)
1. The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures.
Antunes B; Zanchi C; Johnston PR; Maron B; Witzany C; Regoes RR; Hayouka Z; Rolff J
PLoS Biol; 2024 Jul; 22(7):e3002692. PubMed ID: 38954678
[TBL] [Abstract][Full Text] [Related]
2.
Van Moll L; De Smet J; Paas A; Tegtmeier D; Vilcinskas A; Cos P; Van Campenhout L
Microbiol Spectr; 2022 Feb; 10(1):e0166421. PubMed ID: 34985302
[TBL] [Abstract][Full Text] [Related]
3. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
[TBL] [Abstract][Full Text] [Related]
5. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa
Moustafa DA; Wu AW; Zamora D; Daly SM; Sturge CR; Pybus C; Geller BL; Goldberg JB; Greenberg DE
mBio; 2021 Jan; 12(1):. PubMed ID: 33436433
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial Peptide Combination Can Hinder Resistance Evolution.
Maron B; Rolff J; Friedman J; Hayouka Z
Microbiol Spectr; 2022 Aug; 10(4):e0097322. PubMed ID: 35862981
[TBL] [Abstract][Full Text] [Related]
7. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in
Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ
mBio; 2017 Oct; 8(5):. PubMed ID: 29089424
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Peptide Exposure Selects for Resistant and Fit Stenotrophomonas maltophilia Mutants That Show Cross-Resistance to Antibiotics.
Blanco P; Hjort K; Martínez JL; Andersson DI
mSphere; 2020 Sep; 5(5):. PubMed ID: 32999081
[TBL] [Abstract][Full Text] [Related]
9. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
Dosler S; Karaaslan E
Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
[TBL] [Abstract][Full Text] [Related]
10. Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.
Chen C; Deslouches B; Montelaro RC; Di YP
Clin Microbiol Infect; 2018 May; 24(5):547.e1-547.e8. PubMed ID: 28882728
[TBL] [Abstract][Full Text] [Related]
11. Parallel Evolution of Tobramycin Resistance across Species and Environments.
Scribner MR; Santos-Lopez A; Marshall CW; Deitrick C; Cooper VS
mBio; 2020 May; 11(3):. PubMed ID: 32457248
[TBL] [Abstract][Full Text] [Related]
12. The Resilience of
Juárez-López D; Morales-Ruiz E; Herrera-Zúñiga LD; González-Carrera Z; Cuevas-Reyes E; Corzo G; Schcolnik-Cabrera A; Villegas E
Curr Med Chem; 2022; 30(1):72-103. PubMed ID: 36082872
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Peptides against Multidrug-Resistant
Ben Hur D; Kapach G; Wani NA; Kiper E; Ashkenazi M; Smollan G; Keller N; Efrati O; Shai Y
J Med Chem; 2022 Jul; 65(13):9050-9062. PubMed ID: 35759644
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial peptide Reg4 ameliorates
Wan X; Wang W; Zhu J; Xiao Y
Microbiol Spectr; 2024 May; 12(5):e0390523. PubMed ID: 38501823
[No Abstract] [Full Text] [Related]
15. Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa.
Murphy RA; Coates M; Thrane S; Sabnis A; Harrison J; Schelenz S; Edwards AM; Vorup-Jensen T; Davies JC
Microbiol Spectr; 2022 Aug; 10(4):e0081322. PubMed ID: 35727066
[TBL] [Abstract][Full Text] [Related]
16. Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in Pseudomonas aeruginosa Acute Infection.
Khil PP; Dulanto Chiang A; Ho J; Youn JH; Lemon JK; Gea-Banacloche J; Frank KM; Parta M; Bonomo RA; Dekker JP
mBio; 2019 Sep; 10(5):. PubMed ID: 31530672
[TBL] [Abstract][Full Text] [Related]
17. The Long-Term Effect of a Nine Amino-Acid Antimicrobial Peptide AS-hepc3
Zhu D; Chen F; Chen YC; Peng H; Wang KJ
Front Cell Infect Microbiol; 2021; 11():752637. PubMed ID: 34676176
[TBL] [Abstract][Full Text] [Related]
18. Mutational background influences
Hernando-Amado S; Laborda P; Valverde JR; Martínez JL
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2109370119. PubMed ID: 35385351
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients.
Marner M; Kolberg L; Horst J; Böhringer N; Hübner J; Kresna IDM; Liu Y; Mettal U; Wang L; Meyer-Bühn M; Mihajlovic S; Kappler M; Schäberle TF; von Both U
Microbiol Spectr; 2023 Feb; 11(1):e0443722. PubMed ID: 36692293
[TBL] [Abstract][Full Text] [Related]
20. Evolution of Antibiotic Tolerance Shapes Resistance Development in Chronic Pseudomonas aeruginosa Infections.
Santi I; Manfredi P; Maffei E; Egli A; Jenal U
mBio; 2021 Feb; 12(1):. PubMed ID: 33563834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
